• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非肿瘤性胆管病：一种算法式方法

Non-neoplastic cholangiopathies: an algorithmic approach.

作者信息

Zacarias Marina Silva, Pria Hanna Rafaela Ferreira Dalla, de Oliveira Rafael Andrade Santiago, Delmonte Luis Fernando, Velloni Fernanda Garozzo, D'Ippolito Giuseppe

机构信息

Departamento de Diagnóstico por Imagem - Escola Paulista de Medicina da Universidade Federal de São Paulo (EPM-Unifesp), São Paulo, SP, Brazil.

出版信息

Radiol Bras. 2020 Jul-Aug;53(4):262-272. doi: 10.1590/0100-3984.2019.0069.

DOI:10.1590/0100-3984.2019.0069
PMID:32904723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7458557/
Abstract

Cholangiopathies are chronic diseases that affect the bile ducts, comprising a heterogeneous group of progressive and potentially fatal entities. The diagnosis of these diseases is a great challenge for radiologists because of the overlapping of their clinical, biochemical, and imaging findings. Nevertheless, identifying the precise etiology is crucial, given that the therapeutic options are distinct and influence the prognosis of the patient. The purpose of this review article is to discuss some of the non-neoplastic causes of cholangiopathies and to provide a useful diagnostic algorithm.

摘要

胆管病是影响胆管的慢性疾病，由一组异质性的进行性且可能致命的病症组成。由于这些疾病的临床、生化和影像学表现存在重叠，其诊断对放射科医生来说是一项巨大挑战。然而，鉴于治疗选择不同且会影响患者预后，确定确切病因至关重要。这篇综述文章的目的是讨论胆管病的一些非肿瘤性病因，并提供一种有用的诊断算法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/3092a55c73b2/rb-53-04-0262-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/759187b0e8ce/rb-53-04-0262-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/9a5962a51e86/rb-53-04-0262-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/9e2d4124d06c/rb-53-04-0262-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/4e077965672a/rb-53-04-0262-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/682b321646a2/rb-53-04-0262-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/fbd81dfabfa0/rb-53-04-0262-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/a747d008fe05/rb-53-04-0262-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/63d63248756e/rb-53-04-0262-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/0e2630b60af9/rb-53-04-0262-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/3092a55c73b2/rb-53-04-0262-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/759187b0e8ce/rb-53-04-0262-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/9a5962a51e86/rb-53-04-0262-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/9e2d4124d06c/rb-53-04-0262-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/4e077965672a/rb-53-04-0262-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/682b321646a2/rb-53-04-0262-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/fbd81dfabfa0/rb-53-04-0262-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/a747d008fe05/rb-53-04-0262-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/63d63248756e/rb-53-04-0262-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/0e2630b60af9/rb-53-04-0262-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819d/7458557/3092a55c73b2/rb-53-04-0262-g10.jpg

相似文献

1
Non-neoplastic cholangiopathies: an algorithmic approach.非肿瘤性胆管病：一种算法式方法
Radiol Bras. 2020 Jul-Aug;53(4):262-272. doi: 10.1590/0100-3984.2019.0069.
2
The Cholangiopathies.胆管疾病
Mayo Clin Proc. 2015 Jun;90(6):791-800. doi: 10.1016/j.mayocp.2015.03.017. Epub 2015 May 6.
3
Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies.胆汁酸与核受体激动剂在纤维性胆管病中的治疗作用
Dig Dis. 2014;32(5):631-6. doi: 10.1159/000360517. Epub 2014 Jul 14.
4
[Inflammatory and neoplastic cholangiopathies.].[炎症性和肿瘤性胆管病。]
Recenti Prog Med. 2018 Dec;109(12):595-599. doi: 10.1701/3082.30744.
5
Genetic determinants of cholangiopathies: Molecular and systems genetics.胆病遗传学研究进展：分子遗传学与系统遗传学
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1484-1490. doi: 10.1016/j.bbadis.2017.07.029. Epub 2017 Jul 27.
6
Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.慢性胆汁淤积性肝病：从组织病理学角度探讨其发病机制
Mol Aspects Med. 2014 Jun;37:35-56. doi: 10.1016/j.mam.2013.10.001. Epub 2013 Oct 17.
7
Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.微小RNA在胆管疾病中的诊断和治疗潜力
Liver Res. 2017 Jun;1(1):34-41. doi: 10.1016/j.livres.2017.03.003. Epub 2017 Apr 26.
8
Large-duct cholangiopathies: aetiology, diagnosis and treatment.大胆管胆管病：病因、诊断与治疗
Frontline Gastroenterol. 2019 Jul;10(3):284-291. doi: 10.1136/flgastro-2018-101098. Epub 2019 Jan 4.
9
New insights on the molecular and cell biology of human cholangiopathies.人类胆管疾病分子与细胞生物学的新见解
Mol Aspects Med. 2008 Feb-Apr;29(1-2):50-7. doi: 10.1016/j.mam.2007.09.007. Epub 2007 Oct 24.
10
Value of magnetic resonance cholangiography (MRC) in primary sclerosing cholangitis (PSC).磁共振胰胆管造影（MRC）在原发性硬化性胆管炎（PSC）中的价值。
Med Sci Monit. 2001 May;7 Suppl 1:114-7.

本文引用的文献

1
Percutaneous transhepatic cholangiobiopsy.经皮肝穿刺胆管活检
Radiol Bras. 2019 Jan-Feb;52(1):41-42. doi: 10.1590/0100-3984.2017.0228.
2
Hemobilia in a patient with arteriobiliary fistula after liver contusion.肝挫伤后动脉胆管瘘患者出现胆道出血。
Radiol Bras. 2018 Nov-Dec;51(6):413-414. doi: 10.1590/0100-3984.2017.0111.
3
Hepatocyte-specific contrast agent-enhanced magnetic resonance cholangiography: perioperative evaluation of the biliary tree.肝细胞特异性造影剂增强磁共振胆管造影：胆管树的围手术期评估
Radiol Bras. 2017 Nov-Dec;50(6):389-394. doi: 10.1590/0100-3984.2015.0213.
4
Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.原发性硬化性胆管炎中的胆管癌及其类似物。
Abdom Radiol (NY). 2017 Dec;42(12):2898-2908. doi: 10.1007/s00261-017-1328-8.
5
Pathobiology of biliary epithelia.胆道上皮的病理生物学。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1220-1231. doi: 10.1016/j.bbadis.2017.06.024. Epub 2017 Jul 15.
6
Imaging of autoimmune biliary disease.自身免疫性胆道疾病的影像学表现。
Abdom Radiol (NY). 2017 Jan;42(1):3-18. doi: 10.1007/s00261-016-0903-8.
7
Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.硬化性胆管炎：临床病理特征、影像学表现及鉴别诊断的系统方法
Korean J Radiol. 2016 Jan-Feb;17(1):25-38. doi: 10.3348/kjr.2016.17.1.25. Epub 2016 Jan 6.
8
Contrast-enhanced magnetic resonance cholangiography with gadoxetic-acid-disodium for the detection of biliary-cyst communication in Caroli disease.钆塞酸二钠增强磁共振胰胆管造影术用于检测卡罗里病中的胆管囊肿交通。
Gastroenterol Hepatol. 2016 Dec;39(10):669-670. doi: 10.1016/j.gastrohep.2015.07.012. Epub 2015 Nov 18.
9
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Gastroenterology. 2015 Nov;149(6):1627-9. doi: 10.1053/j.gastro.2015.08.031. Epub 2015 Sep 15.
10
Bile Duct Injury after Transcatheter Arterial Chemoembolization: Risk Factors and Clinical Implications.经导管动脉化疗栓塞术后胆管损伤：危险因素及临床意义
Hepatogastroenterology. 2014 Jun;61(132):947-53.